Popular Acne Treatments Under Fire: Lab Report Finds Cancer-Causing Chemical in Clinique, Clearasil Products

pendent U.S. laboratory has raised concerns about the safety of some popular acne treatments. Valisure, a Connecticut-based lab, claims to have detected “unacceptably high levels” of benzene, a known carcinogen, in certain products from brands like Estée Lauder’s Clinique, Reckitt Benckiser’s Clearasil, and other over-the-counter and prescription acne medications.

The report sent shockwaves through the beauty and healthcare industries, prompting investigations and causing concern among consumers.

What is Benzene and Why is it a Concern?

Benzene is a colorless liquid found in various industrial processes and is classified as a human carcinogen by the International Agency for Research on Cancer (IARC). Exposure to benzene has been linked to various health risks, including leukemia, blood disorders, and certain types of cancer.

What Do the Lab Reports Say?

Valisure claims to have tested several acne treatment products and found concerning levels of benzene in some. The report states that the levels detected were “substantially different” from previous cases of benzene contamination in consumer products, such as sunscreens and hand sanitizers.

According to Valisure, the benzene in these acne treatments appears to be a byproduct of the benzoyl peroxide, a common ingredient used to fight acne. The report further suggests that these levels might exceed safety limits set by the U.S. Food and Drug Administration (FDA).

What is the Industry Response?

The companies mentioned in the report have issued various statements. Estée Lauder, the owner of Clinique, stated that they stand by the safety and efficacy of their products, claiming the level of benzene detected is “within acceptable industry standards.”

Reckitt Benckiser, the owner of Clearasil, stated that the findings from the report “reflect unrealistic scenarios rather than real-world conditions” and emphasized the safety of their products when used as directed.

What is the FDA Doing?

The FDA has not yet officially responded to Valisure’s report. However, the agency is responsible for ensuring the safety and efficacy of over-the-counter and prescription drugs. It is expected that the FDA will investigate the claims and take appropriate action if necessary.

What Should Consumers Do?

While the long-term health risks associated with the reported levels of benzene in these acne treatments are still being investigated, the situation highlights the importance of consumer awareness.

Here are some steps you can take:

  • Consult your healthcare provider to discuss your concerns and alternative acne treatment options.
  • Monitor the FDA website for official updates and recommendations related to the reported findings.
  • Consider contacting the manufacturers of the products you use to learn more about their response to the reports.

It is important to remember that this is a developing situation, and further investigation is needed to understand the full extent of the potential risks. Consumers are advised to stay informed and consult with their healthcare providers for personalized guidance.


A Beacon of Hope: Breast Cancer Vaccine Shows Promise in Preventing Recurrence

Leave a Reply

Your email address will not be published. Required fields are marked *

Emiratisation Details For UAE Business Know About Corporate TAX-UAE